With over 15 years’ senior management experience in biotech, from start-up through to marketing authorization, we understand the multitude of challenges you face in your life science venture. We appreciate that the requisite human and financial resources, or expertise, are not always at hand to meet these challenges. We provide professional advice and operational support to bridge these gaps, and access to a network of expertise and potential investors, to help achieve success for your venture.
Lukas served as Chief Financial Officer at APEIRON Biologics AG from 2005 to 2015. In his role he helped manage the growth of the company from a start-up to a company with 30+ employees developing early stage research projects as well as multiple mid- to late-stage clinical programs through to marketing authorization. He handled various equity and debt-based financing rounds, in- and out-license agreements, spin-outs, and his responsibilities included legal affairs, business development, administration, HR and investor relations.
Shane previously served as Chief Scientific Officer at Akron Molecules AG, taking the company from start-up into phase II clinical development. He is experienced in preclinical and clinical development, fund raising, business development, operations, regulatory and IP strategy. He has worked in multiple therapeutic areas in both human and veterinary drug development and has specialist expertise in drug repurposing.